Health
US to widen inquiry into AstraZeneca COVID vaccine destined for Australia – Sydney Morning Herald
The US regulator has broadened its investigation of a serious illness in AstraZeneca’s COVID-19 vaccine study, a development closely watched by local regulators…
AstraZeneca has confirmed it is still awaiting the green light from US regulators to resume its US trials. The pharma giant’s Australian office wouldn’t comment further on how any delays would affect the timeline for when Australians receive the vaccine if successful.
Meanwhile, there was better news for the vaccine in Europe overnight, with reports the European Medicines Agency is expected to announce a “rolling review” of the Oxford/AstraZeneca candidate this week.
This would mean the Europe…
-
General22 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News22 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News21 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business23 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…